News

Study finds dosing strategy may affect immunotherapy outcomes

 

Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based

How human cells and pathogenic shigella engage in battle

 

One member of a large protein family that is known to stop the spread of bacterial infections by prompting infected human cells to self-destruct appears to kill the infectious bacteria instead.